Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Intravenous Ondansetron 8mg (4ml): Administered at least 5 minutes before performing spinal anaesthesia
Given via a labeled 4ml syringe by the monitoring anaesthesiologist
Intervention2
Sponsors
T S Misra medical college and hospital
Eligibility
Inclusion criteria
Inclusion criteria: -Patients of either gender undergoing elective infra umbilical procedure under spinal Anaesthesia. -Age between 20-60years. -ASA Grade I or II patients with no contraindication for central neuraxial blockade. -Patients providing informed written consent.
Exclusion criteria
Exclusion criteria: ASA Grade III or IV. Pregnant patients Patients who are hemodynamically unstable. Patients with study drug allergy. Patients with difficulty in communication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The purpose of this prospective, cross sectional, study is to compare the efficacy of i.v. ondansetron with a placebo in reducing the incidence of hypotension, bradycardia caused by spinal anesthesia as primary outcomeTimepoint: All hemodynamic parameters such as Heart Rate, Systolic blood pressure (SP), diastolic blood pressure (DBP), and Mean Arterial ressure (MAP) will be recorded from baseline, 1 min, 3min, 6 min and so on tor every 3 min for 30 min and after 30 min every 5 min till 40 min after spin l anaesthesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| perioperative shivering as secondary outcomeTimepoint: 12 MONTHS | — |
Countries
India
Contacts
Public ContactDr Jasmine Kaur
T S Misra medical college and hospital
Outcome results
None listed